Cargando…
Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up
INTRODUCTION: We studied the costs of formal and informal care in relation to Alzheimer’s disease (AD) progression. METHODS: 231 persons with AD with a family caregiver were followed up for 5 years. The Clinical Dementia Rating Scale—Sum of Boxes (CDR-SB) was used to measure AD progression. Health a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581391/ https://www.ncbi.nlm.nih.gov/pubmed/34255025 http://dx.doi.org/10.1093/ageing/afab144 |
_version_ | 1784596797796122624 |
---|---|
author | Jetsonen, Viivi Kuvaja-Köllner, Virpi Välimäki, Tarja Selander, Tuomas Martikainen, Janne Koivisto, Anne M |
author_facet | Jetsonen, Viivi Kuvaja-Köllner, Virpi Välimäki, Tarja Selander, Tuomas Martikainen, Janne Koivisto, Anne M |
author_sort | Jetsonen, Viivi |
collection | PubMed |
description | INTRODUCTION: We studied the costs of formal and informal care in relation to Alzheimer’s disease (AD) progression. METHODS: 231 persons with AD with a family caregiver were followed up for 5 years. The Clinical Dementia Rating Scale—Sum of Boxes (CDR-SB) was used to measure AD progression. Health and social care unit costs were used for formal care costs. An opportunity cost method for lost leisure time was applied to analyse the cost of informal care. RESULTS: Total cost of care in early stage AD (CDR-SB ≤ 4) was 16,448€ (95% CI 13,722–19,716) annually. In mild (CDR-SB 4.5–9), moderate (CDR-SB 9.5–15.5) and severe (CDR-SB ≥ 16) AD, the total costs were 2.3, 3.4 and 4.4 times higher, respectively. A one-unit increase in CDR-SB increased the total, formal and informal costs by 15, 11 and 18%, respectively. CONCLUSIONS: Compared to early AD, the costs of total, formal and informal care are remarkably higher already in mild AD. This finding emphasises early diagnosis, interventions and family support for persons with AD and their caregivers. |
format | Online Article Text |
id | pubmed-8581391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-85813912021-11-12 Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up Jetsonen, Viivi Kuvaja-Köllner, Virpi Välimäki, Tarja Selander, Tuomas Martikainen, Janne Koivisto, Anne M Age Ageing Research Paper INTRODUCTION: We studied the costs of formal and informal care in relation to Alzheimer’s disease (AD) progression. METHODS: 231 persons with AD with a family caregiver were followed up for 5 years. The Clinical Dementia Rating Scale—Sum of Boxes (CDR-SB) was used to measure AD progression. Health and social care unit costs were used for formal care costs. An opportunity cost method for lost leisure time was applied to analyse the cost of informal care. RESULTS: Total cost of care in early stage AD (CDR-SB ≤ 4) was 16,448€ (95% CI 13,722–19,716) annually. In mild (CDR-SB 4.5–9), moderate (CDR-SB 9.5–15.5) and severe (CDR-SB ≥ 16) AD, the total costs were 2.3, 3.4 and 4.4 times higher, respectively. A one-unit increase in CDR-SB increased the total, formal and informal costs by 15, 11 and 18%, respectively. CONCLUSIONS: Compared to early AD, the costs of total, formal and informal care are remarkably higher already in mild AD. This finding emphasises early diagnosis, interventions and family support for persons with AD and their caregivers. Oxford University Press 2021-07-10 /pmc/articles/PMC8581391/ /pubmed/34255025 http://dx.doi.org/10.1093/ageing/afab144 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Research Paper Jetsonen, Viivi Kuvaja-Köllner, Virpi Välimäki, Tarja Selander, Tuomas Martikainen, Janne Koivisto, Anne M Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up |
title | Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up |
title_full | Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up |
title_fullStr | Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up |
title_full_unstemmed | Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up |
title_short | Total cost of care increases significantly from early to mild Alzheimer’s disease: 5-year ALSOVA follow-up |
title_sort | total cost of care increases significantly from early to mild alzheimer’s disease: 5-year alsova follow-up |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581391/ https://www.ncbi.nlm.nih.gov/pubmed/34255025 http://dx.doi.org/10.1093/ageing/afab144 |
work_keys_str_mv | AT jetsonenviivi totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup AT kuvajakollnervirpi totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup AT valimakitarja totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup AT selandertuomas totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup AT martikainenjanne totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup AT koivistoannem totalcostofcareincreasessignificantlyfromearlytomildalzheimersdisease5yearalsovafollowup |